The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson’s Disease Model

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|14|10|1350-1366

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.10, 2015-12, pp. : 1350-1366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1530-1541

Bentham Science Publishers

Access to resources Recommend Favorite

Ginkgo Biloba Extract in an Animal Model of Parkinson’s Disease: A Systematic Review

By  

Current Neuropharmacology, Vol. 11, Iss. 4, 2013-07 ,pp. : 430-435

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase and Neuroinflammation in Parkinson's Disease Neurodegeneration

By  

Current Neuropharmacology, Vol. 8, Iss. 1, 2010-03 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl   Henchcliffe Claire  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Dopaminergic substitution in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite